🇺🇸 FDA
Patent

US 9598693

Oligomeric compounds and compositions for the use in modulation of micrornas

granted A61PA61P3/06A61P35/00

Quick answer

US patent 9598693 (Oligomeric compounds and compositions for the use in modulation of micrornas) held by Ionis Pharmaceuticals, Inc. expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P3/06, A61P35/00, A61P43/00